Henan Cancer Hospital: all 234 studies
Page 3 of 3. Open to participants first (130), then studies with results posted, then the rest; newest registration first within each.
- Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian CancerStatus unknownNCT03942068Phase 2
- Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional AdenocarcinomaStatus unknownNCT03939962Phase 2
- Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell MalignanciesStatus unknownNCT03881774Phase 1
- CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell LymphomaStatus unknownNCT03881761Phase 1
- Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLCStatus unknownNCT03790228Phase 1
- SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung CancerStatus unknownNCT03755115Phase 2
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.CompletedNCT03735966Phase 2
- A Real World Study of Apatinib in Treatment of Patients With Gastric CarcinomaStatus unknownNCT03735511
- A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast CancerActive, not recruitingNCT03691051Phase 2
- BCMA-CAR-T in Relapsed/Refractory Multiple MyelomaStatus unknownNCT03664661Phase 1
- The Application of 3T MRI in Esophageal CancerStatus unknownNCT03635619
- Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell LymphomaStatus unknownNCT03540303Phase 1
- The Real World Study of Apatinib for Gastric Cancer Treatment in Henan ProvinceStatus unknownNCT03478943
- S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLCStatus unknownNCT03457337Phase 2
- The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / GastroesophagealStatus unknownNCT03451942Phase 2
- A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT03424291Phase 2
- An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal CancerStatus unknownNCT03415815
- Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal CarcinomaCompletedNCT03413436Phase 4
- Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal CancerStatus unknownNCT03397199Phase 2
- Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung CancerStatus unknownNCT03389087Phase 2
- Clinical Study of Apatinib as the Second-line Therapy in Malignant MelanomaStatus unknownNCT03383237Phase 2
- Study of Apatinib as the Maintenance Therapy in Advanced Lung AdenocarcinomaStatus unknownNCT03376737Phase 2
- Study of BCMA CAR-T in Multiple MyelomaStatus unknownNCT03322735Phase 1/2
- CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.Status unknownNCT03263208Phase 1/2
- Apatinib Treatment for Advanced Esophagus CancerStatus unknownNCT03170310Phase 2
- Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.Status unknownNCT03163381Phase 2
- Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal CancerWithdrawnNCT03110939Not applicable
- The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell LymphomaStatus unknownNCT03101709Phase 1
- Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic CancerTerminatedNCT03002831Phase 2
- The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).Status unknownNCT02924753Phase 1
- Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR MutationStatus unknownNCT02737774Phase 2
- Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell LymphomaStatus unknownNCT02733380Phase 2
- Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung AdenocarcinomaTerminatedNCT02621333Phase 2
- Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell CarcinomaCompletedNCT02395705Phase 3